home / stock / achv / achv news

ACHV News and Press, Achieve Life Sciences Inc. From 09/17/20

Stock Information
Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com
Menu
ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...
ACHV - Achieve Life Sciences (ACHV) Presents At H.C. Wainwright 22nd Annual Global Investment Conference

The following slide deck was published by Achieve Life Sciences, Inc. in conjunction with this Read more ...

ACHV - Achieve Life Sciences rallies on Buy initiation at Lake Street

Lake Street initiated Achieve Life Sciences ( ACHV +11.0% ) with a Buy rating, PT $30; past 6 months the stock has generated 117%. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ACHV - Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual Conference

SEATTLE and VANCOUVER, BC , Sept. 10, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that cytisinicline data w...

ACHV - Achieve Life Sciences to Present at Upcoming Investor Conferences

SEATTLE and VANCOUVER, BC , Sept. 3, 2020 /PRNewswire/ --   Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will present at ...
ACHV - Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2020 Results - Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer Cindy Jacobs - Executive Vice President & Chief Medical Officer Jo...

ACHV - Achieve Life Sciences EPS beats by $0.79

Achieve Life Sciences (NASDAQ: ACHV ) : Q2 GAAP EPS of -$1.68 beats by $0.79 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

ACHV - Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program

SEATTLE and VANCOUVER, British Columbia , Aug. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
ACHV - Achieve Life Sciences prices equity offering at $10.50/share

Achieve Life Sciences (NASDAQ: ACHV ) down  ~7%  premarket, after pricing its previously announced public offering of ~476k shares at $10.50/share, discount of ~10% of last close of $11.72. More news on: Achieve Life Sciences, Inc., Stocks on the move, Healthcare stocks news,...

ACHV - Achieve Life Sciences Announces Pricing of $6.5 Million Public Offering

SEATTLE and VANCOUVER, BC , Aug. 4, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced t...

ACHV - Achieve Life Sciences Announces Proposed Public Offering

SEATTLE and VANCOUVER, BC, Aug. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced a...
Previous 10 Next 10